NCT04044105 is a NA clinical trial of Pamphlet education in Opioid Use and Disposal, sponsored by Rush University Medical Center.

Who is sponsoring NCT04044105?

NCT04044105 is sponsored by Rush University Medical Center.

What drugs are being tested in NCT04044105?

Interventions in NCT04044105: Pamphlet education, Pamphlet education + texts.

What condition does NCT04044105 study?

NCT04044105 studies Opioid Use and Disposal.

Is NCT04044105 still recruiting?

NCT04044105 is currently completed. Last updated 30 August 2021.

Last reviewed 2021-08-30 · How we verify

NCT04044105

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impacting the Disposal of Unused Opioid

Completed NA Last updated 30 August 2021

What this trial tests

NA trial testing Pamphlet education in Opioid Use and Disposal in 563 participants. Completed in 31 December 2019.

Timeline

1 August 2018

Primary endpoint
3 June 2019

31 December 2019

Quick facts

Lead sponsor	Rush University Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	563
Start date	1 August 2018
Primary completion	3 June 2019
Estimated completion	31 December 2019
Sites	1 location across United States

Drugs / interventions tested

Pamphlet education
Pamphlet education + texts

Conditions studied

Opioid Use and Disposal — all drugs for Opioid Use and Disposal →

Sponsor

Rush University Medical Center

Who can join

18 and older, any sex, with Opioid Use and Disposal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the rates of proper opioid disposal in patients receiving an educational brochure compared to an automated text message delivered directly to patients' cell phones alongside the brochure, compared to no education on the subject.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Rush University Medical Center trials

Trials by the same sponsor.

NCT07278076 — Clinical Decision-Making During FEES: The Impact of Residue Amount and Location · NA · not yet recruiting
NCT07088120 — PRECISION-CPR: PRecision-Controlled Ventilation in CPR · NA · not yet recruiting
NCT06894719 — Oral Tranexamic Acid After Total Knee Arthroplasty · Phase 4 · not yet recruiting
NCT06229392 — A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer · Phase 1 · withdrawn
NCT07452406 — Protocolized Weaning of High-Flow Nasal Cannula in Adult Patients · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04044105 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rush University Medical Center
Last refreshed: 30 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04044105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing